# General Fusion Group Ltd.: financial statements, quarterly

GFUZ · Nasdaq · CIK 2074850 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gfuz.md) · [Financials](/companies/gfuz/financials.md) · [Filings](/companies/gfuz/filings.md) · [Insiders](/companies/gfuz/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gfuz/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: |
| Operating income | $m | [(0.0)](/filings/0001104659-25-100853.md) | [(0.1)](/filings/0001104659-25-111381.md) | [(0.2)](/filings/0001104659-26-105499.md) |
| Income tax | $m | not reported | not reported | [0.0](/filings/0001104659-26-105499.md) |
| Net income | $m | [(0.0)](/filings/0001104659-25-111381.md) | [0.4](/filings/0001104659-25-111381.md) | [(12.0)](/filings/0001104659-26-105499.md) |
| Diluted EPS | $ per share | [0.00](/filings/0001104659-25-100853.md) | not reported | not reported |
| Basic EPS | $ per share | [0.00](/filings/0001104659-25-100853.md) | not reported | not reported |

- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2025-03-11) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | [0.0](/filings/0001104659-25-100853.md) | [1.2](/filings/0001104659-25-111381.md) | [0.7](/filings/0001104659-26-105499.md) | [0.7](/filings/0001104659-26-105499.md) |
| Current assets | $m | not reported | not reported | [0.0](/filings/0001104659-25-100853.md) | [1.2](/filings/0001104659-25-111381.md) | [0.9](/filings/0001104659-26-105499.md) | [0.8](/filings/0001104659-26-105499.md) |
| Total assets | $m | not reported | not reported | [0.1](/filings/0001104659-25-100853.md) | [232](/filings/0001104659-25-111381.md) | [234](/filings/0001104659-26-105499.md) | [236](/filings/0001104659-26-105499.md) |
| Current liabilities | $m | not reported | not reported | not reported | [0.1](/filings/0001104659-25-111381.md) | [0.1](/filings/0001104659-26-105499.md) | [0.1](/filings/0001104659-26-105499.md) |
| Total liabilities | $m | not reported | not reported | [0.1](/filings/0001104659-25-100853.md) | [9.3](/filings/0001104659-25-111381.md) | [9.3](/filings/0001104659-26-105499.md) | [23.2](/filings/0001104659-26-105499.md) |
| Shareholders' equity | $m | [0.0](/filings/0001104659-26-024740.md) | [0.0](/filings/0001104659-26-105499.md) | [0.0](/filings/0001104659-25-111381.md) | [(8.1)](/filings/0001104659-25-111381.md) | [(8.3)](/filings/0001104659-26-105499.md) | [(22.2)](/filings/0001104659-26-105499.md) |

- Cash and equivalents: us-gaap:Cash, us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: |
| Operating cash flow | $k | [(220)](/filings/0001104659-26-105499.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | Q2 FY2025 (2025-06-30) |
| --- | --- | ---: |
| Diluted shares (weighted) | thousands of shares | [6,667](/filings/0001104659-25-100853.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 52,988,419 at 2026-07-13, from the cover of the [20-F filed 2026-07-16](/filings/0001104659-26-084015.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.